Active Pharmaceutical Ingredients Released by Oral Medication Dispensing Robots - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Active Pharmaceutical Ingredients Released by Oral Medication Dispensing Robots

Description:

Re-Aerosolizing the Parata RDS Pill Dust in a Measurement Chamber ... from exposure to aerosolized active pharmaceutical compounds in the particle ... – PowerPoint PPT presentation

Number of Views:478
Avg rating:3.0/5.0
Slides: 36
Provided by: albur
Category:

less

Transcript and Presenter's Notes

Title: Active Pharmaceutical Ingredients Released by Oral Medication Dispensing Robots


1
Active Pharmaceutical Ingredients Released by
Oral Medication Dispensing Robots
David Alburty, Pamela Murowchick, Andrew Page
  • 7C.05
  • AAAR 27th Annual Conference and Exposition,
    Orlando, FL, October 22, 2008

2
EPA Air Pollution Standards
  • The Clean Air Act established two types of
    national air quality standards for particle
    pollution PM-10 and PM-2.5.
  • Fine particle (PM-2.5) standards are based on
    their correlation with serious health problems
    ranging from increased symptoms, hospital
    admissions and emergency room visits, and
    premature death for people with heart or lung
    disease.

3
Indoor Air Quality Concerns
  • Intake Fraction It is generally accepted that
    the likelihood of inhalation of particles from an
    indoor source is 100 1000 times that for
    inhalation of particles from a similar source
    while outdoors.
  • The effect of proximity to an indoor source is
    interesting and complicated.

4
  • Due to the known hazards from airborne PM, we
    studied the potential for pill dust generated
    by the agitation of pills in common dispensing
    machines found in retail pharmacies to be emitted
    as respirable dust.

5
Potential Hazards of Airborne Pill Dust
  • Airborne active chemical compounds found in pill
    dust have the potential to alter body functions.
  • Fine fraction pill dust can be conserved and
    recirculated throughout the pharmacy through
    typical heating, ventilation and air conditioning
    systems.
  • There are no defined safe levels for these types
    of particles in most cases.

6
Comparison Study
  • We compared PM-10 and PM-2.5 emissions from
    two leading robotic prescription dispensing
    machines, the ScriptPro SP 200 and the
    McKesson/Parata RDS. These are widely used in
    thousands of drugstores across the U.S. As a
    control, we also conducted sampling in pharmacies
    where pills are counted dispensed manually.

7
Manual Pharmaceutical Dispensing
  • 80 of prescriptions filled are dispensed as
    loose tablets or capsules supplied in bulk stock
    bottles.
  • The pills are counted out manually into a slot on
    a filling tray using a spatula, and then poured
    from the tray to a prescription vial, according
    to the physicians directions, then labeled.
  • Any excess pills are poured back into the stock
    bottle.
  • Pharmacies with dispensing robots also do some
    manual counting.

8
Robotic Dispensing
  • Robotic dispensing machines count pills into
    vials, print and apply labels, and sort the
    prescriptions by patient name.
  • They are able to fill at a much faster rate than
    manual filling and with less potential for
    errors.
  • Pills are dispensed from large storage cells
    within the machine and transported into the vials
    in various ways, according to the design of the
    particular machine.

9
ScriptPro SP 200
  • In this machine, pills are maneuvered into
    prescription vials using a rotating platen inside
    each storage cell. They are counted by an
    optical sensor as they drop into the vial.

10
Parata RDS
  • This machine uses differential air pressure
    inside the dispensing cell to agitate the pills.
  • While the pills are being agitated, compressed
    air jets force them through a nozzle and into a
    prescription vial.
  • They are counted using optical sensors as they
    pass through the nozzle.

11
Pill Dust on Parata RDS
  • Pill dust was plainly visible on both the inside
    and outside of the Parata RDS. This was not
    observed on the ScriptPro SP 200.
  • An analysis was performed to determine if the
    Parata RDS dust contained active pharmaceutical
    compounds of respirable particles.

12
Collecting Pill Dust from the Parata RDS
13
Parata RDS Pill Dust Analyzed
  • Nine separate dust samples were collected from
    various parts of the Parata RDS and sent to
    Inovatia Laboratories for analysis using
    LC/DAD/MS.
  • A limited method was developed and sample
    aliquots were analyzed.
  • The results indicated 6 -16 peaks in each sample
    which included Acetaminophen, Levofloxacin,
    Mirtazapine, Methocarbamol, Carisoprodol,
    Loratadine, Diazepam and Valacyclovir, and
    unidentified compounds.

14
Cleaning the Parata RDS
  • Manufacturer recommended operation of the Parata
    RDS requires that dust generated during the
    dispensing process be removed from the pill count
    sensors.
  • This is accomplished by using canned air
    supplied by the manufacturer.
  • Instruments showed that the resulting dust cloud
    remains in the pharmacy for several minutes after
    cleaning.

15
Nanoparticles in Pill Dust
  • Oral pharmaceutical tablets and capsules are
    often comprised of active nanoparticles, which
    can be embedded in excipients and released in
    pill dust.

16
Re-Aerosolizing the Parata RDS Pill Dust in a
Measurement Chamber
  • Pill dust from the Parata RDS was re-aerosolized
    in an Aerosol Test Chamber at AlburtyLab using a
    Small Scale Powder Disperser.
  • An Aerodynamic Particle Sizer (APS) and a
    Scanning Mobility Particle Sizer (SMPS) were used
    to measure the particle size distribution.

17
Findings Fine Particulate Matter and Active
Pharmaceutical Compounds
  • 94 of the respirable particles (by number)
    reaerosolized from dust samples removed from the
    Parata RDS were in the PM-2.5 range.
  • The samples were also shown by Mass Spectrometry
    to include active pharmaceutical compounds
    (example Ibuprofen).

18
Testing the Air in 15 Pharmacies
  • Five Parata RDS.
  • Five ScriptPro SP200.
  • Five with no automated system.

19
Test Methodology
  • Pharmacy aerosols were observed over 24-hr
    periods.
  • Emissions of pill dust from dispensing operations
    were sensed using an Aerodynamic Particle Sizer
    Spectrometer (APS).
  • Air samples were collected with paired quartz
    fiber filters near dispensing areas and were
    analyzed by Inovatia Laboratories using
    HPLC/DAD/MS at MU.

20
Air Sampling Parata RDS
  • The APS sampling tube and reference filters were
    stationed on the edges of the dispensing area at
    approximate breathing height.

21
Air Sampling - Parata RDS
22
Air Sampling - ScriptPro SP 200
23
Air Sampling - Manual Counting
24
Data Analysis
  • Dispensing data logs were merged with APS
    readings to correlate emission levels with drugs
    dispensed.
  • Activity logs were also merged with APS readings
    to show other activities which could interfere
    with instrument readings such as vacuuming, heavy
    customer traffic, trash collection, ventilation,
    etc.
  • Some medications were found to be dustier than
    others.

25
ScriptPro SP 200
26
Parata RDS
27
Manual Dispensing
28
PM-2.5 in 15 Pharmacies
29
ScriptPro SP 200 PM-2.5
30
4 More ScriptPro SP 200
31
Parata RDS PM-2.5
32
4 More Parata RDS
33
Manual Counting PM-2.5
34
4 More Non-Robotic Pharmacies
35
Comparison of Results vs. EPA National Ambient
Air Quality Standards
  • The data show that PM-2.5 and PM-10 emission
    peaks from Parata RDS dispensing and cleaning
    operations frequently exceed EPA NAAQ standards.
  • Given that personnel in pharmacies are working
    indoors and are subject to proximity, constant
    exposure, and constrained dispersion factors,
    there may be an increased health impact risk.

36
Additional Study Recommended
  • Extensive studies have been performed for certain
    classes of worker such as in coal mines, cotton
    mills, etc.
  • This is believed to be the first study addressing
    exposure to personnel in pharmacies arising from
    pill dust.
  • Data collected during this study could be further
    analyzed to plan a health risks effects study
    from exposure to aerosolized active
    pharmaceutical compounds in the particle size
    ranges observed.

37
Acknowledgment
This work was supported by ScriptPro LLC of
Mission, Kansas www.scriptpro.com
38
Contact Information
David S. Alburty AlburtyLab, Inc. 128 E. Main
St., Drexel, MO 64742 www.alburtylab.com dalburty_at_
alburtylab.com
Write a Comment
User Comments (0)
About PowerShow.com